Nephrocare Health Services Limited has submitted a regulatory disclosure to BSE Limited and National Stock Exchange of India Limited regarding scheduled investor meetings. The disclosure is made pursuant to Regulation 30 read with Schedule III of the SEBI Listing Regulations.
The company officials will be attending an investor conference hosted by Citi on June 15th and 16th, 2026, starting from 10:00 A.M. IST onwards. The event is characterized as a Non-Deal Roadshow to be held in Mumbai. The meetings will include both group sessions and one-on-one interactions.
The company explicitly states that discussions during these interactions will be based solely on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during these meetings.
The disclosure includes a note that changes to the schedule may occur due to exigencies on the part of either the host (Citi) or the company. This disclosure is available on the company's website at www.nephroplus.com.
The document is signed by Kishore Kathri, Company Secretary & Compliance Officer (ICSI Membership No. F9895), who serves as the authorized signatory for Nephrocare Health Services Limited.